Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  3-Pyridinecarboxamide,2-methyl-(9CI)

3-Pyridinecarboxamide,2-methyl-(9CI)

Basic information Safety Supplier Related

3-Pyridinecarboxamide,2-methyl-(9CI) Basic information

Product Name:
3-Pyridinecarboxamide,2-methyl-(9CI)
Synonyms:
  • 3-Pyridinecarboxamide,2-methyl-(9CI)
  • 2-methylnicotinamide
  • 2-Methyl-3-PyridinecarboxaMide
  • 3-Pyridinecarboxamide, 2-methyl-
  • 3-Pyridinecarboxamide,2-methyl-(9CI) ISO 9001:2015 REACH
  • 2-Methylnicotinamide (~12% inorganics)
  • Olutasidenib Impurity 33
  • 2-Methylnicotinamide, 97%, QA-0097
CAS:
58539-65-4
MF:
C7H8N2O
MW:
136.15
Product Categories:
  • Pyridines
  • AMIDE
Mol File:
58539-65-4.mol
More
Less

3-Pyridinecarboxamide,2-methyl-(9CI) Chemical Properties

Melting point:
158 °C
Boiling point:
271.9±28.0 °C(Predicted)
Density 
1.157±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
DMSO (Slightly), Methanol (Slightly, Sonicated)
form 
Solid
pka
14.85±0.50(Predicted)
color 
White to Off-White
More
Less

Safety Information

HS Code 
2933399990
More
Less

3-Pyridinecarboxamide,2-methyl-(9CI) Usage And Synthesis

Chemical Properties

White solid

Uses

2-Methylnicotinamide (~12% inorganics) can be used as JAK inhibitors to treat autoimmune disease or cancer.

Definition

ChEBI: 2-methylnicotinamide is a pyridinecarboxamide that is nicotinamide substituted by a methyl group at C-2. It has a role as a metabolite. It is functionally related to a nicotinamide.

Synthesis

3222-56-8

58539-65-4

General procedure for the synthesis of 2-methylnicotinamide from 2-methylnicotinic acid: 2-methylnicotinic acid (0.537 mg, 3.9 mmol) was dissolved in 20 mL of DMF at 0 °C, and HATU (1.56 g, 4.1 mmol) and DIPEA (0.72 mL, 4.1 mmol) were added sequentially. Subsequently, ammonia (NH3) was passed into the reaction system for 15 min. The reaction mixture was stirred overnight at room temperature. After completion of the reaction, the paste was obtained by filtration, washed with cold DMF and the filtrate was discarded. The mother liquor was concentrated and purified by normal phase chromatography with the eluent being MeOH solution of CH2Cl2/7N NH3 (93:7, v/v). The final white solid product 2-methylnicotinamide (405 mg, 76% yield) was obtained. The structure of the product was confirmed by 1H NMR (400 MHz, CDCl3): δ 1.34 (s, 9H), 1.36 (d, J = 6.64 Hz, 3H), 2.56 (s, 3H), 4.32-4.40 (m, 1H), 7.15-7.19 (m, J = 8.20 Hz, 1H), 7.68 (d, J = 8.20 Hz, 1H) .

References

[1] Patent: WO2007/73303, 2007, A2. Location in patent: Page/Page column 38
[2] Patent: EP1193265, 2002, A2. Location in patent: Page 76-77
[3] Patent: US2013/281397, 2013, A1. Location in patent: Paragraph 0438; 0439
[4] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3168 - 3185
[5] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 58 - 66,9

3-Pyridinecarboxamide,2-methyl-(9CI)Supplier

JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
Shangchem Co., Ltd.
Tel
+86-21-68182121
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Email
bin.wu@shlschem.com
Shanghai Ennopharm Co., Ltd.
Tel
+86 (21) 6435-5022
skychemical Co.Ltd
Tel
021-20958197 20965099
Email
sales@skychemical.com